Contact the BPC-157 TB-500 editorial desk

Editorial inquiries only

Use the form below to reach the editorial desk about the BPC-157 TB-500 digest — a flagged citation, a study we missed, a correction to the regulatory summary, or a question about how we read a finding. We read every message in that spirit, and corrections to the published record are the messages we most want to receive.

A few things this desk cannot do, stated plainly so no one is misled. It gives no medical advice, no dosing guidance, and no treatment recommendations. It is no clinic; it evaluates no patients and issues no prescriptions. It sells, supplies, sources, and prices nothing — not the blend, not either constituent — and it can direct no one to a pharmacy, clinic, or vendor. Questions about whether a compounded preparation is appropriate for a person belong with an appropriately licensed prescriber, not with an editorial project — that boundary is the whole point of the site, not a disclaimer bolted onto it.

Send a message

The form collects a name, an email address, and a message, and routes it to the editorial desk. No data is sold or shared, and the site stores nothing beyond what is needed to reply. For regulatory questions, the Wolverine legal status and FDA 503A category page already lays out the FDA record and cites it; for the science, the references register is the fastest route to source.